Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Cv Sciences Inc (OP:CVSI)

0.0324 UNCHANGED
Streaming Delayed Price Updated: 3:15 PM EDT, Mar 31, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Cv Sciences Inc

< Previous 1 2 3 4 5 6 7 8 9 Next >
Marijuana Stock Movers For March 26, 2025
Via Benzinga
Topics Cannabis
Exposures Cannabis
Marijuana Stock Movers For March 24, 2025
Via Benzinga
Topics Cannabis
Exposures Cannabis
Cannabis Stock Gainers And Losers From March 21, 2025
Via Benzinga
Topics Cannabis
Exposures Cannabis
Cannabis Stock Gainers And Losers From March 20, 2025
Via Benzinga
Topics Cannabis
Exposures Cannabis
Cannabis Stock Movers For March 17, 2025
Via Benzinga
Topics Cannabis
Exposures Cannabis
Marijuana Stock Movers For March 14, 2025
Via Benzinga
Topics Cannabis
Exposures Cannabis
Bearish Sentiment Across The Cannabis Space - Check Full Movers For March 13, 2025
Via Benzinga
Topics Cannabis
Exposures Cannabis
Cannabis Stock Movers For March 10, 2025
Via Benzinga
Topics Cannabis
Exposures Cannabis
Cannabis Stock Movers For February 17, 2025
Via Benzinga
Topics Cannabis
Exposures Cannabis
Bearish Sentiment Across The Cannabis Space - Check Full Movers For January 20, 2025
Via Benzinga
Topics Cannabis
Exposures Cannabis
Cannabis Stock Movers For January 9, 2025
Via Benzinga
Topics Cannabis
Exposures Cannabis
Marijuana Stock Movers For December 25, 2024
Via Benzinga
Topics Cannabis
Exposures Cannabis
Cannabis Stock Gainers And Losers From December 24, 2024
Via Benzinga
Topics Cannabis
Exposures Cannabis
Hemp-Focused CV Sciences Expands Via New Cannabis Acquisition, Here's What Investors Need To Know
CV Sciences, Inc. (OTCQB: CVSI) a hemp-focused wellness company announced on Thursday it's acquiring Extract Labs, Inc., a manufacturer and distributor of premium cannabinoid products including... 
Via Benzinga
Topics Cannabis
Exposures Cannabis
CV Sciences Q3: Revenue Stable Amid New Launches, Financing
CV Sciences Q3 2024 financial results: stable $3.9M revenue, improved 46% gross margin, new products, and nearing cash flow break-even. 
Via Benzinga
Cannabis Stock Gainers And Losers From November 1, 2024
Via Benzinga
Topics Cannabis
Exposures Cannabis
Cannabis Stock Gainers And Losers From October 31, 2024
Via Benzinga
Topics Cannabis
Exposures Cannabis
Cannabis Stock Gainers And Losers From October 30, 2024
Via Benzinga
Topics Cannabis
Exposures Cannabis
Cannabis Stock Movers For October 29, 2024
Via Benzinga
Topics Cannabis
Exposures Cannabis
Cannabis Stock Movers For October 24, 2024
Via Benzinga
Topics Cannabis
Exposures Cannabis
Marijuana Stock Movers For October 23, 2024
Via Benzinga
Topics Cannabis
Exposures Cannabis
Marijuana Stock Movers For October 22, 2024
Via Benzinga
Topics Cannabis
Exposures Cannabis
Cannabis Stock Movers For October 22, 2024
Via Benzinga
Topics Cannabis
Exposures Cannabis
Marijuana Stock Movers For October 18, 2024
Via Benzinga
Topics Cannabis
Exposures Cannabis
Bullish Monday For Marijuana Stocks - Body and Mind, Global Compliance Among Top Gainers
Via Benzinga
Topics Cannabis
Exposures Cannabis
Marijuana Stock Movers For October 10, 2024
Via Benzinga
Topics Cannabis
Exposures Cannabis
Cannabis Stock Gainers And Losers From October 9, 2024
Via Benzinga
Topics Cannabis
Exposures Cannabis
Cannabis Stock Gainers And Losers From October 4, 2024
Via Benzinga
Topics Cannabis
Exposures Cannabis
Marijuana Stock Movers For October 3, 2024
Via Benzinga
Topics Cannabis
Exposures Cannabis
Cannabis Stock Movers For September 25, 2024
Via Benzinga
Topics Cannabis
Exposures Cannabis
< Previous 1 2 3 4 5 6 7 8 9 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.